Home>Topics>Stocks>Progenics Pharmaceuticals

Progenics Pharmaceuticals PGNX

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
    1. What Does A Positive Adcom Mean For Progenics And Salix?

      Headlines

      Tue, 17 Jun 2014

      However, I rarely write about what happens after an Advisory Committee (Adcom) makes a decision. In the case of Progenics ( PGNX ), I believe that the Adcom has just handed down a significant decision that will help the company (should the FDA adopt it

    2. $5 Or Less: 3 Small, Speculative Biotechs On The Move

      Headlines

      Tue, 17 Jun 2014

      By Bret Jensen : I have found some of my biggest winners have come from small cap stocks selling for less than $5 a share. These companies receive scant analyst coverage, and one must do the research to uncover hidden gems. I personally look at myriad factors when analyzing the space. Insider ...

    3. Progenics schedules conference call to discuss Ad Comm recommendation

      Headlines

      Thu, 12 Jun 2014

      Progenics Pharmaceuticals ( PGNX +9.2% ) CEO Mark Baker will comment tomorrow in a conference call on the FDA's Anesthetic and Analgesic Drug Products Ad

    4. Ad Comm recommendation bodes well for opioid-induced constipation drugs

      Headlines

      Thu, 12 Jun 2014

      the FDA, would potentially mitigate a time-consuming and expensive hurdle for the drug makers in their NDA application efforts. Related tickers: ( CBST -0.6% ) ( NKTR ) ( SLXP +3.2% ) ( THRX -2.4% ) ( PGNX ) Post your comment!

    5. Progenix trading halted while Ad Comm meets

      Headlines

      Wed, 11 Jun 2014

      The NASDAQ halts trading of Progenix Pharmaceuticals ( PGNX ) while the FDA's Anesthetic and Analgesic Drug Products Ad Comm meets today and tomorrow to discuss the potential cardiovascular

    6. After Hour Gainers / Losers

      Headlines

      Mon, 9 Jun 2014

      Top gainers, as of 5:15 p.m.: KANG +4.5% . PGNX +3.0% . ONNN +2.3% . TPLM +2.3% . SNMX +2.2% . Top losers, as of 5:15 p.m.: CASY -3.0% . SMCI -2.6% . MCK -2.5% . IMS -2.4% . REED -2.2% . Post your comment!

    7. The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming

      Headlines

      Mon, 2 Jun 2014

      By Scott Matusow : Written by Scott Matusow. Coming up on June 10th, 2014, Orexigen Therapeutics ( OREX ) expects a Food and Drug Administration (FDA) decision concerning its weight loss drug, NB32 (Contrave). Contrave was initially rejected by the FDA due to a single issue cardiovascular safety ...

    8. Progenics Pharma Poised For A Potential Price Increase Ahead Of June 11 Adcom

      Headlines

      Fri, 30 May 2014

      biotech map a bit in the beginning of 2014, but has a chance to regain investor interest in the near term. Progenics Pharmaceuticals ( PGNX ) is a biotechnology company that focuses on developing oncology and therapeutics worldwide. At this time

    9. It’s Never Too Early: Roth 401(k)s and Other Fun Stuff

      Headlines

      Thu, 3 Apr 2014

      Progenics Pharmaceuticals PGNX announced on March 6 that it would backtrack and reformulate the oral version opioid bowel dysfunction drug MNTX to make it more

    10. Shares of Salix, Progenics drop after FDA rejects drug

      Headlines

      Mon, 30 Jul 2012

      (Reuters) - Shares of Salix Pharmaceuticals Ltd and Progenics Pharmaceuticals tumbled after U.S. health regulators declined to approve wider use of their drug for opioid-induced constipation and...

    « Prev12345Next »
    Content Partners